Document is current

Any future updates will be listed below

Synthesis and biological evaluation of seliciclib derivatives as potent and selective CDK9 inhibitors for prostate cancer therapy

Crossref DOI link: https://doi.org/10.1007/s00706-020-02727-x

Published Online: 2021-01-13

Published Print: 2021-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark